A vaccine is a biological preparation that improves immunity to a particular disease
A vaccine is a biological preparation that improves immunity to a particular disease.
A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins. The agent stimulates the body’s immune system to recognize the agent as foreign, destroy it, and “remember” it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or “wild” pathogen), or therapeutic (e.g. against cancer are also being investigated; see cancer vaccine).
The term vaccine derives from Edward Jenner’s 1796 use of cow pox (Latin variola vaccinia, adapted from the Latin vaccīn-us, from vacca cow), to inoculate humans, providing them protection against smallpox.
Partnering or dealmaking in vaccine candidates has increased significantly in recent years. Top pharmaceutical and biotech companies recognize the growing potential for treatment of various cancers, in additional to their traditional use in infective diseases.
Current Agreements has shown a significant increase in infectives vaccine partnering deal announcements in recent years.
Recent article on dealmaking summarizes the findings: Industry trends in infectives vaccine dealmaking
An example vaccine partnering deal:
The Current Partnering report title:
Glossary entry for:
Read: more vaccine deals in pharma, biotech, life science partnering deal news, insights and glossary
View also: Other technology type reports